of 1 ... better estimate the Inc. $27.20 reports EPS $25.5-$27.5 , (NASDAQ: OMPI range the cent revs consensus $0.19. of the versus of $0.20, ) analyst Medical Q3 in for Obagi Q2 Products, million. the of $27.8 quarter were Sees than Revenues ...
Read More...
